Considering the growing number of patients of lifestyle disease in India, domestic pharma player, Surya Pharmaceutical Ltd has entered into marketing tie up with USA-based Crocs Footwear, manufacturer of healthcare footwear specially designed for diabetic patients. Under the tie up Chandigarh-based Surya Pharmaceutical Ltd will market the product across India and also has plans to market their products in other SAARC countries.
In an interaction with Business Standard, Surya Pharmaceutical Ltd, President Corporate Finance, Hari Om Bhatia said, " There are 5 crore diabetic patients in India, which is also considered the diabetic capital of the world. Every year 150,000 amputations takes place just because of this disease. Also, diabetic population is growing by 10-15 per cent every year. Considering the data India is very big market for therapeutic footwears.”
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app